Breast Radiotherapy for carcinoma, intraductal, noninfiltrating

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Feb 2025: Trial started, NCT06902311
  2. 30 Mar 2025: Trial registered, NCT06902311

The trials

NCT06902311: Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

State
Under way
Phase
Phase 2
People
90 planned
Started
19 Feb 2025
Primary completion
Feb 2028
Arms
WBI-SIB
Results
None posted
  1. 19 Feb 2025: Trial started
  2. 30 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.